Achieve Life Sciences, Inc. Contractual Obligation
Achieve Life Sciences, Inc. (ACHV) had Contractual Obligation of $37.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligation · last filed 2026-08-11
- 2026-06-30: Contractual Obligation $37.00K.
- 2026-03-31: Contractual Obligation $53.00K.
- 2025-12-31: Contractual Obligation $71.00K.
- 2025-09-30: Contractual Obligation $86.00K.
| Period end | Contractual Obligation |
|---|---|
| 2026-06-30 | $37.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $53.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $71.00K 10-K · filed 2026-03-24 |
| 2025-09-30 | $86.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $104.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $115.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $131.00K 10-K · filed 2025-03-11 |
| 2024-09-30 | $22.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $38.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $56.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $74.00K 10-K · filed 2024-03-28 |
| 2023-09-30 | $90.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $108.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $122.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $138.00K 10-K · filed 2023-03-16 |
| 2022-09-30 | $21.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $39.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $58.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $74.00K 10-K · filed 2022-03-10 |
| 2021-09-30 | $91.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $111.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $126.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $167.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $212.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $262.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $308.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $377.00K 10-K · filed 2020-03-13 |
| 2019-09-30 | $423.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $479.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $526.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $574.00K 10-K · filed 2019-03-14 |
| 2018-09-30 | $384.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $410.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $470.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $602.00K 10-K · filed 2018-03-01 |
| 2017-09-30 | $278.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $398.00K 10-Q · filed 2017-07-31 |
| 2017-03-31 | $400.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $492.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |